ArticleScientific reports2024

Efficacy of glutathione inhibitor eprenetapopt against the vulnerability of glutathione metabolism in SMARCA4-, SMARCB1- and PBRM1-deficient cancer cells.

Mariko Sasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.